Combined genotype analysis of GSTM1 and GSTT1 polymorphisms in a Polish population

Human Biology

Volumn 75, Issue 2, 2003, Pages 301-307

  Kargas, Christos ^a   Krupa, Renata ^a   Walter, Zofia ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Cancer; Epidemiology; Genotype; GSTM1; GSTT1; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GROUPS BY AGE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; INHERITANCE; MALE; NETHERLANDS; NORMAL HUMAN; NULL ALLELE; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; POPULATION GENETICS; POPULATION RESEARCH; PREVALENCE; SEX DIFFERENCE;

EID: 0037911510     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: 10.1353/hub.2003.0033     Document Type: Article

References (24)

1. Arand, M., R. Mühlbauer, J. Hengstler et al. 1996. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem. 236:184-186.
2. Bell, D.A., J.A. Taylor, D.F. Paulson et al. 1993. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. Natl. Cancer Inst. 85:1159-64.
3. Brockmöller, J., I. Cascorbi, R. Kerb et al. 1996. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 56:3915-3925.
4. Chen, H., D.P. Sandler, J.A. Taylor et al. 1996. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295-297.
5. Chenevix-Trench, G., J. Young, M. Coggan et al. 1995. Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility to colon cancer and age of onset. Carcinogenesis 16:1655-1657.
6. Cotton, S.C., L. Sharp, J. Little et al. 2000. Glutathione S-transferase polymorphisms and colorectal cancer: A HuGE review. Am. J. Epidemiol. 151:7-23.
7. Evans, D.A., J. Seidegard, and N. Narayanan. 1996. The GSTM1 genetic polymorphism in healthy Saudi Arabians and Filipinos, and Saudi Arabians with coronary atherosclerosis. Pharmacogenetics 6:365-367.
8. Fennell, T.R., J.P. MacNeel, R.W. Morris et al. 2000. Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: Effects of glutathione S-transferase T1-null and M1-null genotypes. Cancer Epidemiol. Biomarkers Prev. 9:705-712.
9. Hayes, J.D., and R.C. Strange. 2000. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154-166.
10. Landi, S. 2000. Mammalian class theta GST and differential susceptibility to carcinogens - A review. Mutat. Res. Rev. 463:247-283.
11. Mannervik, B., and U.H. Danielson. 1988. Glutathione transferases - Structure and catalytic activity. CRC Crit. Rev. Biochem. 23:283-337.
12. McLellan, L.I., and C.R. Wolf. 1999. Glutathione and glutathione-dependent enzymes in cancer drug resistance. Drug Resist. Update 2:153-164.
13. Pessah-Rasmussen, H., L. Stavenow, J. Seidegard et al. 1990. Lack of glutathione transferase activity in intermittent claudication. Int. Angiol. 9:70-74.
14. Schroder, K.R., F.A. Wiebel, S. Reich et al. 1995. Glutathione S-transferase (GST) theta polymorphism influences background SCE rate. Arch. Toxicol. 69:505-507.
15. Strange, R.C., P.W. Jones, and A.A. Fryer. 2000. Glutathione S-transferases: Genetics and role in toxicology. Toxicol. Lett. 112:357-363.
16. Slomski, R., J. Kwiatkowska, H. Chlebowska et al. 1999. DNA isolation by guanidine isotiocyanine acid (GTC). In Progress in Molecular Biology: Examples of DNA Analysis, R. Slomski, ed. Poznan, Poland, 5.
17. Stroombergen, M.C., and R.H. Waring. 1999. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum. Exp. Toxicol. 18:141-145.
18. Taioli, E., D. Mari, C. Franceshi et al. 2001. Polymorphisms of drug-metabolizing enzymes in healthy nonagenarians and centenarians: Difference at GSTT1 locus. Biochem. Biophys. Res. Commun. 280:1389-1392.
19. To-Figueras, J., M. Gene, J. Gomez-Catalan et al. 2000. Polymorphism of glutathione S-transferase M3: Interaction with glutathione S-transferase M1 and lung cancer susceptibility. Biomarkers 5:73-80.
20. Trizna, Z., G.L. Clayman, M.R. Spitz et al. 1995. Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am. J. Surg. 170:499-501.
21. Walter, Z., M. Gawronska, C. Kargas et al. 1999. Effect of methylparathione on glutathione S-transferase isoenzymes in different rat tissues. Folia Biochim. Biophys. 14:149-155.
22. Walter, Z., and C. Kargas. 2001. Chances in the enzymatic activity of glutathione S-transferases from human peripheral blood lymphocytes after the action of cis- and trans-diammindichlorplatinum (II). Acta Biolog. Cracoviens. 43:23-29.
23. Wilson, M.H., P.J. Grant, L.J. Hardie et al. 2000. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J. 14:791-796.
24. Wu, D., X. Wang, D. Chen et al. 2000. Metabolic gene polymorphisms and risk of dysmenorrhea. Epidemiology 11:648-653.